Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Aspirin Market From 2025 to 2029?

The size of the aspirin market has been on a consistent rise in recent years. Projected growth is expected from $2.56 billion in 2024 to $2.66 billion the following year, with a compound annual growth rate (CAGR) of 3.7%. The expansion during the historical phase has been driven by the demand for pain and analgesic management, increased awareness of cardiovascular health, anti-inflammatory benefits, preventive strategies for strokes and heart attacks, and the treatment of fever and headaches, rheumatic fever, and arthritis.

The aspirin industry is predicted to experience significant expansion in the upcoming years. It’s projected to surge to a value of $3.31 billion by 2029, with a compound annual growth rate (CAGR) of 5.7%. The predicted growth in the forecast period can be ascribed to the rising prevalence of long-term diseases, potential advantages in treating neurological diseases, advancements in the pharmaceutical industry, greater acceptance in under-developed regions, and increasing trend towards self-care. Major trends to watch for the forecast period encompass research on cancer prevention, combination treatments, personalized medicinal strategies, tailored dosage forms and distribution systems, telemedicine, and self-treatments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9154&type=smp

What Elements Are Contributing To Growth In The Aspirin Market?

The rising incidents of arthritis are anticipated to fuel the expansion of the aspirin market. Arthritis is a health issue characterized by discomfort and inflammation in the joints. Aspirin is a non-steroidal anti-inflammatory drug that alleviates chronic pain from arthritis among other conditions by mitigating inflammation, lessening pain, and enhancing function. As the number of arthritis cases rise, so does the consumption of aspirin. For instance, the Health and Safety Executive (HSE), a government agency in the UK, reported in November 2023 that the total number of employees impacted by work-related musculoskeletal disorders had reached 473,000 during 2022-2023, displaying a prevalence of 1,400 out of 100,000 workers. In addition, 132,000 fresh cases were recorded, suggesting an incidence of 390 out of 100,000 workers. Consequently, the aspirin market is experiencing growth due to the escalating occurrence of arthritis.

Which Segments Are Detailed In The Global Aspirin Market Report?

The aspirin market covered in this report is segmented –

1) By Product: Prescription, OTC

2) By Route Of Administration: Oral, Rectal, Parenteral

3) By Dosage Form: Tablets, Capsules, Injections, Suppositories

4) By Application: Cardiovascular Disease, Pain, Fever, O Inflammation, Other Applications

5) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Prescription Aspirin: Low-Dose Aspirin (81 Mg), High-Dose Aspirin (325 Mg)

2) By OTC (Over-the-Counter) Aspirin: Regular Strength Aspirin (325 Mg), Extra-Strength Aspirin (500 Mg), Buffered Aspirin, Aspirin Combinations

Which Emerging Trends And Strategic Shifts Are Shaping The Aspirin Market?

Notable corporations involved in the aspirin industry are capitalizing on strategic collaborations to facilitate technology integration and broaden their market influence. A strategic partnership often signifies a mutual relationship between two or more entities wherein they amalgamate their resources, know-how, and endeavors to attain shared targets or aims. For instance, in February 2023, Bayer AG, a life sciences firm based in Germany, and Huma Therapeutics Limited or ‘Huma’, a digital health enterprise located in the UK, collaborated to roll out the Bayer Aspirin Heart Risk Assessment online instrument. This tool assists users to recognize their susceptibility to contract cardiovascular disease within the subsequent ten years and enables them to discuss the outcomes with their healthcare provider. Huma originated an algorithm able to forecast long-term cardiovascular disease risk, based on data from the Biobank in the UK. Bayer Aspirin offers individuals access to the Heart Risk Assessment tool that features an easy-to-use 15 question survey. Depending on the users’ responses, the instrument will gauge their risk degree – whether high, average or low – of developing cardiovascular afflictions by comparing their feedback against the results from the research populace.

Who Are The Key Contributors To Growth In The Aspirin Market?

Major companies operating in the aspirin market include Bayer AG, Allegiant Health, Par Pharmaceutical, Cardinal Health Inc., Nanjing pharmaceutical factory Co. Ltd., JQC (Huayin) Pharmaceutical Co. Ltd., LNK International Inc., Bal Pharma Limited, Trumac Healthcare, Perrigo Company PLC, Alta Laboratories Ltd., Zhenjiang Gaopeng Pharmaceutical Co. Ltd., J.M. Loveridge Ltd., Mayne Pharma Group Limited, St. Joseph’s Aspirin, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Hetero Labs Ltd., Jubilant Generics Ltd., Lupin Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/aspirin-global-market-report

Which Region Is Projected To Lead The Aspirin Market By 2025?

Asia-Pacific was the largest region in the aspirin market in 2024. The regions covered in the aspirin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9154&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model